SC Warns Patanjali Against False Medical Claims, Imposes Potential Rs 1 Cr Penalty
Brands Companies FMCG News

SC Warns Patanjali Against False Medical Claims, Imposes Potential Rs 1 Cr Penalty

SC Issues Contempt Notice To Patanjali, Ramdev For Misleading Ads

The Supreme Court of India has directed Patanjali Ayurveda, led by Baba Ramdev, to refrain from making false claims against modern medicines and vaccines, based on a petition filed by the Indian Medical Association (IMA).

The court has warned Patanjali of substantial penalties, potentially reaching up to Rs 1 crore, if it persists in making false claims about cures.

During the hearing, the court emphasised the seriousness of the matter and cautioned Patanjali against disseminating misleading information. The court’s order is a response to the IMA’s concerns about Patanjali’s advertisement released in July of the previous year. The ad controversially stated, “Misconceptions spread by Allopathy: Save yourself and the country from the misconceptions spread by Pharma and Medical Industry.”

In addition to cautioning Patanjali, the court has called upon the government to present a proposal addressing the issue of misleading medical advertisements.

As the case progresses, it is expected to set a precedent for handling instances of misinformation in the healthcare industry.

Leave a Reply

Discover more from BW Retail World

Subscribe now to keep reading and get access to the full archive.

Continue reading